Sign in
4

Changes in Ownership

Larimar Therapeutics, Inc. Filed Acc 0001062993-23-011547

Chief Financial Officer bought 5,000 shares at $3.73 ($18,632)

From the SEC's structured data for this filing

Trades in this filing

Celano Michael · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-05-17 Purchase : show line 1 in the form +5,000 $3.73 $18,632 112,746 D
Open-market purchases · 5,000 sh · avg $3.73 · $18,632
Loading xslF345X04/form4.xml…